+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Resynchronization Therapy (CRT) Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139738
The global market for Cardiac Resynchronization Therapy (CRT) Devices was estimated at US$6.5 Billion in 2023 and is projected to reach US$10.9 Billion by 2030, growing at a CAGR of 7.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Cardiac Resynchronization Therapy (CRT) Devices Market - Key Trends and Drivers Summarized

What Are Cardiac Resynchronization Therapy (CRT) Devices and Why Are They Essential?

Cardiac Resynchronization Therapy (CRT) devices are critical tools in the management of heart failure, particularly for patients suffering from electrical conduction problems that impair the heart's ability to beat efficiently. These devices are designed to restore the coordinated contraction of the heart's ventricles, improving its overall pumping efficiency. CRT devices typically consist of a pacemaker or an implantable cardioverter-defibrillator (ICD) equipped with leads that are placed in both ventricles of the heart. By delivering synchronized electrical pulses to the ventricles, CRT devices correct the misalignment in heartbeats that is common in patients with heart failure or bundle branch block. This form of therapy is often prescribed for individuals who have moderate to severe heart failure and who have not responded well to conventional treatments. The ultimate goal of CRT is to reduce the symptoms of heart failure, such as shortness of breath and fatigue, improve the quality of life, and lower the risk of hospitalization or death. With heart failure affecting millions of people worldwide, CRT devices represent a vital intervention in the management of this chronic and often debilitating condition.

How Is Technology Enhancing the Effectiveness of CRT Devices?

The technological evolution of CRT devices has significantly enhanced their effectiveness, safety, and the overall patient experience. One of the key advancements in this field has been the development of adaptive CRT systems that automatically adjust pacing based on a patient's activity levels and heart rhythms. These systems utilize sophisticated algorithms to optimize therapy by ensuring the heart beats as efficiently as possible under various conditions, such as rest or exercise. Another major innovation is the integration of remote monitoring capabilities, allowing real-time transmission of patient data to healthcare providers. This enables clinicians to continuously monitor the performance of the device and the patient's heart condition without the need for frequent in-person visits. Remote monitoring not only improves patient outcomes through timely adjustments in therapy but also reduces the need for hospitalizations and emergency interventions. Additionally, the miniaturization of CRT devices has made them less invasive and more comfortable for patients. These smaller, more efficient devices now have longer battery lives and are easier to implant, reducing the risk of complications during surgery. The inclusion of wireless technology in CRT devices has further improved patient care, allowing for seamless communication between the device and external monitoring systems. As technology continues to advance, the precision and efficacy of CRT devices in treating heart failure are expected to grow, offering even better outcomes for patients.

What Are the Key Market Trends in Cardiac Resynchronization Therapy Devices?

Several important trends are driving the cardiac resynchronization therapy devices market, shaped by advancements in technology, demographic shifts, and changes in healthcare delivery. One of the most notable trends is the increasing prevalence of heart failure globally, largely driven by aging populations and the rising incidence of conditions such as hypertension, diabetes, and coronary artery disease, all of which contribute to the onset of heart failure. This has fueled the demand for CRT devices as a treatment option for patients who are not responding to medications alone. Another key trend is the growing adoption of remote patient monitoring solutions. With healthcare systems increasingly moving towards digital platforms, CRT devices with remote monitoring capabilities are becoming more widespread. This not only improves patient management but also aligns with the global trend towards telemedicine and home-based care. Furthermore, the ongoing miniaturization of CRT devices and the development of leadless versions are set to revolutionize the market by making the devices less invasive and reducing the potential for lead-related complications. Regulatory approval of these innovative devices is accelerating, particularly in developed regions like North America and Europe, where regulatory agencies have streamlined processes to get these life-saving technologies to patients faster. Lastly, the expansion of healthcare coverage and reimbursement policies in several regions is making CRT devices more accessible to a broader patient population, driving increased adoption.

What Are the Factors Driving Expansion of the CRT Devices Market?

The growth in the cardiac resynchronization therapy devices market is driven by several key factors tied to advancements in technology, shifts in healthcare trends, and changing patient demographics. A primary driver is the rising prevalence of heart failure across the globe, particularly in aging populations. As the number of heart failure patients continues to increase, so does the demand for effective treatment options like CRT, which is especially critical for patients who do not respond to conventional heart failure therapies. The ongoing advancements in CRT technology, such as the development of adaptive CRT devices and the integration of remote monitoring capabilities, have significantly enhanced the appeal of these devices. Adaptive systems that automatically adjust pacing parameters based on patient-specific needs improve therapy effectiveness and reduce the likelihood of complications. Moreover, the widespread adoption of telemedicine and remote patient monitoring has boosted the demand for CRT devices that can seamlessly transmit data, allowing for more proactive and efficient management of heart failure patients. The shift toward home-based care, further accelerated by the COVID-19 pandemic, has emphasized the importance of remote monitoring in chronic disease management. Another driver is the increasing focus on reducing hospital readmissions and improving long-term outcomes, which has led healthcare systems to embrace value-based care models. CRT devices, by improving heart function and reducing the need for emergency interventions, align well with these healthcare goals. Additionally, advancements in device miniaturization and battery life are making CRT devices more accessible, less invasive, and more durable, leading to higher patient satisfaction and better overall adoption. Finally, favorable regulatory policies and expanding healthcare coverage, especially in developed markets, have made it easier for patients to access these life-saving devices, further fueling market growth.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the CRT-Defibrillator (CRT-D) segment, which is expected to reach US$7.8 Billion by 2030 with a CAGR of a 7.4%. The CRT-Pacemaker (CRT-P) segment is also set to grow at 8.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $1.8 Billion in 2023, and China, forecasted to grow at an impressive 7.3% CAGR to reach $1.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Cardiac Resynchronization Therapy (CRT) Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cardiac Resynchronization Therapy (CRT) Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Cardiac Resynchronization Therapy (CRT) Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Cardiovascular, Biotronik SE & Co. KG, Boston Scientific Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 42 Featured):

  • Abbott Cardiovascular
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medico SpA
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Osypka Medical GmbH

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Cardiac Resynchronization Therapy (CRT) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Heart Failure Throws the Spotlight on Cardiac Resynchronization Therapy (CRT) Devices
  • Technological Advancements in CRT Devices Propel Growth in Heart Failure Treatment
  • Increasing Use of Remote Monitoring Expands Addressable Market Opportunity for CRT Devices
  • Growing Adoption of AI in Health Monitoring Spurs Demand for Smarter CRT Devices
  • Integration of Telemedicine Generates New Opportunities for CRT Device Management
  • Expanding Use of Advanced Imaging Techniques Drives Precision in CRT Device Implantation
  • Rising Demand for Non-Invasive Monitoring Propels Growth in CRT Device Usage
  • Innovations in Battery Longevity and Device Miniaturization Accelerate Demand for Next-Generation CRT Devices
  • Increasing Need for Long-Term, Real-Time Monitoring Spurs Use of Advanced CRT Devices
  • Advancements in Device Connectivity and Data Analytics Propel Growth of CRT Solutions
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Cardiac Resynchronization Therapy (CRT) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for CRT-Defibrillator (CRT-D) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for CRT-Pacemaker (CRT-P) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 18: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 20: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 26: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
JAPAN
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 29: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 32: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CHINA
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 35: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 38: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
EUROPE
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 41: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 42: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
FRANCE
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 50: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 53: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
GERMANY
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 56: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 59: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ITALY
  • Table 62: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 65: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 68: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 71: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 86: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
  • Table 89: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Cardiovascular
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medico SpA
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Osypka Medical GmbH

Table Information